(Q28299553)

English

Bornaprine vs placebo in Parkinson disease: double-blind controlled cross-over trial in 30 patients

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Bornaprine vs placebo in Parkinson disease: double-blind controlled cross-over trial in 30 patients (English)

0 references

1 reference

0 references

R Cantello

1

0 references

A Riccio

series ordinal

2

0 references

M Gilli

series ordinal

3

0 references

M Delsedime

series ordinal

4

0 references

L Scarzella

series ordinal

5

0 references

M Aguggia

series ordinal

6

0 references

B Bergamasco

series ordinal

7

0 references

language of work or name

English

0 references

publication date

February 1986

0 references

published in

Italian journal of neurological sciences

0 references

volume

7

0 references

issue

1

0 references

page(s)

139-43

0 references

cites work

[Comparative neurophysiologic studies on tremor-inhibiting substances].

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3514543

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Kr 339, a new tremor-inhibiting preparation for the therapy of Parkinson's syndrome].

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3514543

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anticholinergic treatment of Parkinson's disease (author's transl)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3514543

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Motor disturbance induced by tremorine and oxotremorine.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3514543

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of bornaprine on parkinsonian tremor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3514543

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Parkinson's disease with agents other than levodopa and dopamine agonists: controversies and new approaches

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3514543

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KR 339 in the treatment of Parkinsonian tremor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3514543

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[On 3-piperidino-1-phenyl-1-bicycloheptenyl-1-propanol (Akineton). 3]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3514543

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Critical analysis of the disability in Parkinson's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3514543

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CLINICAL EXPERIENCES WITH DEPOT FORMS OF ANTI-PARKINSON DRUGS (AKINETON AND KR 339 KNOLL)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3514543

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

0 references

0 references

(Q28299553)

Bornaprine vs placebo in Parkinson disease: double-blind controlled cross-over trial in 30 patients

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)